Disease relevance of Fee-for-Service Plans

• Health outcomes for a chronic disease in prepaid group practice and fee for service settings. The case of rheumatoid arthritis [1].

Psychiatry related information on Fee-for-Service Plans

• Fee-for-service insurance versus cost financing. Impact on mental health care systems [2].

High impact information on Fee-for-Service Plans

• Increases from 10% market share to 20% market share were associated with 2.0% decreases in Part A fee-for-service expenditures and 1.5% decreases in Part B fee-for-service expenditures [3].
• In 1994 and 1997, fee-for-service physicians were more likely than other physicians to prefer use of CSF support while maintaining treatment dose and schedule instead of using dose-reduction strategies, and, when using a CSF, they were more likely to support longer CSF treatment schedules (P <.05 for both scenarios) [4].
• Among U.S. physicians, those who said they used erythropoietin frequently were more likely to be in fee-for-service than managed care settings (OR = 2.2; 95% CI: 1.3 to 3.7) [5].
• CONCLUSIONS: Both HMO and fee-for-service patients would likely benefit from greater use of beta-blockers and cholesterol-lowering agents [6].
• Expenditure and utilization patterns of aged Medicare beneficiaries with chronic obstructive respiratory disease (COPD) (n = 42,472) were compared with all Medicare beneficiaries (n = 1,221,615) using a 5% nationally representative sample of aged Medicare beneficiaries participating in the fee-for-service program in 1992 [7].

Chemical compound and disease context of Fee-for-Service Plans

• OBJECTIVE: To prospectively compare inpatient and outpatient utilization rates between prepaid (PPD) and fee-for-service (FFS) insurance coverage for patients with chronic disease [8].

Biological context of Fee-for-Service Plans

• The purpose of this study is (1) to compare the length of stay (LOS) and total medical expense of appendectomy of fee for service (FFS) and T/PPS and (2) to compare the clinical outcome of wound healing after discharge of the two systems by telephone interview [9].

Associations of Fee-for-Service Plans with chemical compounds

• The estimated costs of preventive services for adolescents under a fee-for-service system were derived from a 1993 survey of nine Blue Cross and Blue Shield plans and four insurance companies [10].
• RESULTS: In the 3 Medicare fee-for-service regions, payment denial due to nonconforming fluorescein angiograms ranged from 17% to 29% by region in 1245 beneficiaries [11].
• An increase in the use of regional anaesthesia occurred but, since a similar increase occurred in the practice of those still on fee-for-service, it cannot be ascribed to the AFP [12].
• METHODS: Drug cohorts were assembled, using population-based fee-for-service Medicaid claims, for patients between 18 and 65 years of age who had received at least one troglitazone (n = 7226) or rosiglitazone (n = 1480) prescription between 1 April, 1997, and 21 March, 2000 [13].
• METHODS: California Medicaid fee-for-service pharmacy claims were analyzed from May 1999 through August 2000 for patients who received risperidone, olanzapine, or quetiapine [14].

Gene context of Fee-for-Service Plans

• The most important determinant of support for CSF use was being in a fee-for-service practice (P < 0.001) [15].
• Care in the demonstration sites was compared with care given in similar counties functioning under a traditional fee-for-service Medicaid system--Ventura County, Calif., and St Louis, Mo [16].
• Male physicians trained before 1974 and physicians receiving fee-for-service were significantly more likely than other physicians to recommend screening by PSA [17].
• Health outcomes and medicaid costs for frail older individuals: a case study of a MCO versus fee-for-service care [18].
• Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients [19].

Analytical, diagnostic and therapeutic context of Fee-for-Service Plans

• DESIGN, SETTING, AND PARTICIPANTS: Historical cohort study of 1355 adult rheumatoid arthritis patients enrolled in the fee-for-service or discounted fee-for-service plans of a nationwide US insurance company [20].
• METHODS: A cross-sectional analysis was conducted on a nationally random sample of 1 217 103 Medicare fee-for-service beneficiaries aged 65 and older living in the United States and enrolled in both Medicare Part A and Medicare Part B during 1999 [21].
• White persons with managed care are also more likely than white persons with fee-for-service coverage to receive mammography and cholesterol screening [22].
• While charging fees-for-service, MHS modifies medical practice in defined ways and seeks to involve patients through supervised self-care [23].
• They then identify commonly used metrics, including relative-value units, total patient-care gross charges, total net patient fee-for-service revenue, total volume per CPT (current procedural terminologies) code by service category and number of patients per physician, discussing their advantages and disadvantages [24].

References